23:17 , May 11, 2018 |  BioCentury  |  Finance

Aslan’s insiders

A disappointing offering on NASDAQ by Aslan Pharmaceuticals Ltd. (TPEx:6497; NASDAQ:ASLN) looks to be the consequence of Taiwan exchange rules that prevented more robust insider participation. So even though big names such as Morningside and...
07:00 , May 2, 2011 |  BC Week In Review  |  Financial News

Aslan completes venture financing

Aslan Pharmaceuticals Pte. Ltd. , Singapore   Business: Cancer, Inflammation, Pulmonary   Date completed: 4/26/11   Type: Venture financing   Raised: $12 million   Investors: BV Healthcare II; Sagamore Bioventures; and other undisclosed investors  ...
23:54 , Apr 26, 2011 |  BC Extra  |  Financial News

Aslan raises $12 million in series A

Aslan Pharmaceuticals Pte Ltd. (Singapore) raised $12 million in a series A round led by BV Healthcare II. Sagamore Bioventures participated along with other undisclosed investors. Aslan plans to in-license preclinical and early clinical compounds...